
Trump cuts millions in taxpayer funding for pushing COVID ‘cover-up'
Springer Nature is an academic publishing company which includes a consortium of science publications. Funding such a thing may seem innocuous, but Springer is a behemoth in the scientific publishing world and prone to error and politicized decision-making.
As Brian Flood reported at Fox News in late June, "The German-owned Springer Nature was forced to issue 2,923 retractions in 2024, according to Retraction Watch. The publishing giant has also been accused of significantly downplaying the COVID lab-leak theory and censoring content to appease the Chinese government. It also has a peer review process that critics believe is dominated by woke groupthink."
Springer has long been considered a company dedicated to political goals and not scientific ones. Their journals had spent much of the pandemic downplaying the COVID-19 lab leak theory concluding in the journal Nature Medicine, as early as March 17, 2020, that, "since we observed all notable SARS-CoV-2 features, including the optimized RBD and polybasic cleavage site, in related coronaviruses in nature, we do not believe that any type of laboratory-based scenario is plausible." The paper was called "The Proximal Origin of SARS-CoV-2" and its goal was to remove all discussion of the lab leak theory.
A House Oversight committee, in July 2023, found that "Dr. Fauci and Dr. Collins tracked the paper through the review and publication process. And finally, Dr. Collins expressed dismay when Proximal Origin did not successfully kill the lab leak theory. He subsequently asked Dr. Fauci if there was anything more they could do. The next day, Dr. Fauci directly cited Proximal Origin from the White House podium."
The committee concluded, "Dr. Collins and Dr. Fauci used Proximal Origin to attempt to kill the lab leak theory. This is the anatomy of a cover-up."
In 2017, Springer "confirmed that it is restricting access to hundreds of articles that cover topics deemed sensitive to Chinese authorities."
The censorship isn't limited to Covid and China. Two years ago, Springer retracted a peer-reviewed paper on gender dysphoria after pressure from activists who did not approve of the findings. Michael Bailey, the author of the study, had never had an article retracted before. This is not science. This is a political point of view.
Springer Nature also charges scientists exorbitant amounts to publish their work. One study found that in just three years, Springer collected $589.7 million in "article processing charges." The researcher on that study found the scientific publishing companies "reach between 30% and 40%, well above most industries."
This is not a company that should be receiving public funds and it's exactly the sort of thing that would have gone unnoticed in previous Republican administrations. Why are we funding any private publishing company, much less a foreign one with a leftist political bent? The Trump administration's laser focus on cost-cutting, but also on making the cuts specifically to politicized, bloated, entities like Springer is worth celebrating.
Transparency is also a focus of the administration. On July 1, National Institutes of Health head Jay Bhattacharya posted about a new NIH policy to release all research to the public as soon as it is published. "The American people should have immediate free access to the science that we so generously fund through the @NIH. Starting today, we do."
The Trump administration cuts to Springer are around $20 million and, a source told Axios, billions more are being evaluated. It's a strong start. Most Americans will be asking why we ever funded a company like this in the first place. President Donald Trump gets to say: we don't anymore.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
ATAI Life Sciences (ATAI) Stock Plunge on Trial Failure News
July 28 - Atai Life Sciences (NASDAQ:ATAI) shares slid 9% in pre?market trading on Monday after Recognify Life Sciences, an Atai?backed company, reported its Phase 2b trial of inidascamine for cognitive impairment linked to schizophrenia missed its primary endpoint. Warning! GuruFocus has detected 6 Warning Signs with ATAI. The oral compound, engineered to modulate multiple neurotransmitter pathways for pro?cognitive effects, failed to outperform placebo on key cognitive measures. Recognify said the results fell short of statistical significance. Atai's CEO acknowledged the setback but highlighted inidascamine's potential in CIAS and other indications. He added that Atai will redirect its efforts toward its wholly?owned psychedelic programs focused on affective disorders. Investors have been closely watching Atai's broader pipeline, which includes compounds targeting depression, PTSD and Alzheimer's disease. This latest trial disappointment adds to a string of mid?stage readouts that have tested market sentiment around biotech firms pivoting to next?generation neuroscience therapies. Despite today's drop, Atai's management reiterated its commitment to advancing its lead psychedelic candidates through upcoming Phase 1 and Phase 2 trials. Based on the one year price targets offered by 6 analysts, the average target price for ATAI Life Sciences NV is $9.83 with a high estimate of $12.00 and a low estimate of $7.00. The average target implies a upside of +175.44% from the current price of $3.57. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 minutes ago
- Yahoo
Darren Walker's new book is still hopeful despite growing inequality as he leaves Ford Foundation
NEW YORK (AP) — Darren Walker needed to be convinced of his new book's relevance. The outgoing Ford Foundation president feared that 'The Idea of America," set to publish in September just before he leaves the nonprofit, risked feeling disjointed. In more than eight dozen selected texts dating back to 2013, he reflects on everything from his path as a Black, gay child from rural Texas into the halls of premiere American philanthropies to his solutions for reversing the deepening inequality of our 'new Gilded Age." 'To be clear, not everything I said and wrote over the last 12 years is worthy of publication," Walker said. A point of great regret, he said, is that he finds American democracy weaker now than when he started. Younger generations lack access to the same 'mobility escalator' that he rode from poverty. And he described President Donald Trump's administration's first six months as 'disorienting' for a sector he successfully pushed to adopt more ambitious and just funding practices. Despite that bleak picture, Walker embraces the characterization of his upcoming collection as patriotic. 'My own journey in America leaves me no option but to be hopeful because I have lived in a country that believed in me,' he said. Walker recently discussed his tenure and the book's call for shared values with the Associated Press inside his Ford Foundation office — where an enlarged picture of a Black child taken by Malian portrait photographer Seydou Keïta still hangs, one of many underrepresented artists' works that populated the headquarters under his leadership. This interview has been edited and condensed for clarity. Q: Upon becoming Ford Foundation's president, you suggested that 'our most important job is to work ourselves out of a job' — a 2013 statement you include in the book. How would you grade your efforts? A: The past 12 years have been both exhilarating and exhausting. Exhilarating because there's never been a more exciting time to be in philanthropy. And exhausting because the political, socioeconomic dynamics of the last 12 years are very worrisome for our future. Philanthropy can play a role in helping to strengthen our democracy. But philanthropy can't save America. I would probably give myself a B or a B-. I don't think where we are as a nation after 12 years is where any country would want to be that had its eye on the future and the strength of our democracy. Q: Is there anything you would do differently? A: In 2013 and those early speeches, I identified growing inequality as a challenge to the strength of our democracy. And a part of that manifestation of growing inequality was a growing sense of disaffection — from our politics, our institutions, our economy. For the first time, a decade or so ago, we had clear evidence that working class white households were increasingly downwardly mobile economically. And the implications for that are deep and profound for our politics and our democracy. We started a program on increasing our investments in rural America, acknowledging some of the challenges, for example, of the trends around the impacts of the opioid epidemic on those communities. I underestimated the depth and the collective sense of being left behind. Even though I think I was correct in diagnosing the problem, I think the strategy to respond was not focused enough on this population. Q: Many people credit you for using Ford Foundation's endowment to increase grantmaking during the pandemic. Is that sort of creativity needed now with the new strains faced by the philanthropic sector? A: One of the disappointments I have with philanthropy is that we don't take enough risk. We don't innovate given the potential to use our capital to provide solutions. I do think that, in the coming years, foundations are going to be challenged to step up and lean in in ways that we haven't since the pandemic. The 5% payout is treated as a ceiling by a lot of foundations and, in fact, it's a floor. During these times when there's so much accumulated wealth sitting in our endowments, the public rightly is asking questions about just how much of that we are using and towards what end. Q: Where do you derive this sense of 'radical hope' at the end of your book? A: As a poor kid in rural Texas, I was given the license to dream. In fact, I was encouraged to dream and to believe that it will be possible for me to overcome the circumstances into which I was born. I've lived on both sides of the line of inequality. And I feel incredibly fortunate. But I'm also sobered by the gap between the privileged and the poor and the working-class people in America. It has widened during my lifetime and that is something I worry a lot about. But I'm hopeful because I think about my ancestors who were Black, enslaved, poor. African Americans, Black people, Black Americans have been hopeful for 400 years and have been patriots in believing in the possibility that this country would realize its aspirations for equality and justice. That has been our North Star. Q: Heather Gerken, the dean of Yale's law school, was recently named as your successor. Why is it important to have a leader with a legal background and an expertise in democracy? A: She is the perfect leader for Ford because she understands that at the center of our work must be a belief in democracy and democratic institutions and processes. She is also a bridge builder. She is a coalition builder. She's bold and courageous. I'm just thrilled about her taking the helm of the Ford Foundation. It is a signal from the Ford Foundation Board of Trustees that we are going to double down on our investment and our commitment to strengthening, protecting and promoting democracy. Q: Youtold AP last year that, when you exited this building for the last time, you'd only be looking forward. What does 'forward' mean to you now? A: I have resolved that I don't want to be a president or a CEO. I don't need to be a president of CEO. I think leaders can become nostalgic and hold onto their own history. Now there's no doubt, I know, that my obituary is going to say, 'Darren Walker, the president of the Ford Foundation." That's the most important job I'll ever have. But hopefully I'll be able to add some more important work to that. ___ Associated Press coverage of philanthropy and nonprofits receives support through the AP's collaboration with The Conversation US, with funding from Lilly Endowment Inc. The AP is solely responsible for this content. For all of AP's philanthropy coverage, visit Solve the daily Crossword
Yahoo
2 minutes ago
- Yahoo
US and China officials meet in Stockholm to discuss how to ease trade tensions
STOCKHOLM, Sweden (AP) — Top trade officials from China and the United States arrived for a new round of talks in Stockholm on Monday in a bid to ease tensions over trade between the world's two biggest national economies. U.S. Treasury Secretary Scott Bessent and Chinese Vice Premier He Lifeng were meeting at the offices of Sweden's prime minister for talks that Bessent has said will likely to lead to an extension of current tariff levels. Analysts say the two envoys could set the stage for a possible meeting between U.S. President Donald Trump and Chinese President Xi Jinping later this year to cement a recent thaw in trade tensions. The talks are the third this year between He and Bessent — nearly four months after Trump upended global trade with his sweeping tariff proposals, including an import tax that shot up to 145% on Chinese goods. China quickly retaliated, sending global financial markets into a temporary tailspin. The Stockholm meeting — following similar talks in Geneva and London in recent months — is set to extend a 90-day pause on those tariffs. During the pause, U.S. tariffs were lowered to 30% on Chinese goods, and China set a 10% tariff on U.S. products. The Trump administration, fresh off a deal on tariffs with the European Union, wants to reduce a trade deficit that came in at $904 billion overall last year — including a nearly $300 billion trade deficit with China alone. China's Commerce Ministry, for its part, said last week that Beijing wants 'more consensus and cooperation and less misperception' from the Stockholm talks. —— Didi Tang and Josh Boak in Washington contributed to this report. Solve the daily Crossword